Loading company…
Tioga Pharmaceuticals develops treatments for gastrointestinal diseases, including inflammatory bowel disease.
Founded in 2005 and based in San Diego, Tioga Pharmaceuticals develops treatments for gastrointestinal diseases such as inflammatory bowel disease and ulcerative colitis. The company raised USD 10.00 mn in funding, including a Series B round led by Thomas, McNerney & Partners in April 2012. Its work focuses on therapies for healthcare providers, hospitals and specialty pharmacies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in